Pharmaceuticals News and Research

RSS

President's signing of America Invents Act a huge win for innovators

Today's historic signing of the America Invents Act represents a huge win for innovators and improves U.S. competiveness globally by aligning new patent laws more closely with those from other countries, said John Lechleiter, Ph.D., Chairman, President and Chief Executive Officer of Eli Lilly and Company.

17 Sep 2011

New diabetes drugs linked to increased risk of pancreatitis and pancreatic cancer

Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer, according to a new UCLA study.

17 Sep 2011

Nanion’s automated patch clamp platforms show unparalleled results using stem cell derived cardiomyocytes

The Patchliner and the SyncroPatch 96 have successfully been used for compound analysis under current- and voltage clamp recording conditions using different stem cell-derived cardiomyocytes. The exceptional cell-platform-compatibility and the unique experimental possibilities offered by Nanion’s platforms open up whole new avenues for compound safety testing.

16 Sep 2011

General Electric establishes two new joint ventures in Russia

Today, GE expanded its position in one of the world's fastest growing markets by finalizing agreements to set up two new joint ventures in Russia which could drive $10 - $15 billion in sales. Under the new JVs, we anticipate orders of energy-efficient heavy-duty gas-fired power generation turbines with total capacity of up to 5 gigawatts of power as well as thousands of high-tech medical diagnostic units in Russia.

16 Sep 2011

New collaboration reinforces Sanofi's translational discovery platform for retinal diseases

The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.

16 Sep 2011

Study shows increase in pediatric medication poisoning

The number of young children admitted to hospitals or seen in emergency departments because they unintentionally took a potentially toxic dose of medication has risen dramatically in recent years, according to a new Cincinnati Children's Hospital Medical Center study.

16 Sep 2011

Unlikely coalition launches effort to aid enrollment of people without insurance

Enroll America, which is a group of health care organizations and companies, is making a health coverage push to boost the new health law.

16 Sep 2011

Teva to invest in CDI for development of novel antiviral drugs

Teva Pharmaceutical Industries Ltd. announced today that it has signed a collaboration option to license and share purchase agreements to invest in Cocrystal Discovery Inc. (CDI), a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases.

16 Sep 2011

Viewpoints: NY Times on uninsured; Wilensky's 'sobering reflection'; caring for aging parents

Nearly one million more Americans went without health insurance in 2010 than in 2009. ... The only consolation was that government insurance programs were able to mitigate some of the damage. ... The new health care reforms will expand Medicaid coverage for the poor and provide subsidies to help middle-income people buy private health insurance.

16 Sep 2011

TCT to showcase major scientific research breakthroughs in cardiovascular medicine

The Cardiovascular Research Foundation has announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2011 scientific symposium. Presented in partnership with the American College of Cardiology (ACC), TCT 2011 is the world's leading educational meeting specializing in interventional cardiovascular medicine and will take place November 7-11, 2011 in San Francisco.

16 Sep 2011

Potential new treatment for fragile X syndrome

Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.

16 Sep 2011

Shorter treatment with telaprevir-based combination regimen may benefit hepatitis C patients

Treatment with a telaprevir-based combination regimen for hepatitis C - heretofore a chronic, destructive and difficult to manage disease - effectively can be shortened to six months in about two-thirds of patients, finds a new study published Thursday in the New England Journal of Medicine.

16 Sep 2011

New study aims to reduce number of pediatric pharmaceutical poisoning

Pharmaceutical poisoning remains a common childhood injury, despite years of concerted prevention efforts, such as improved safe guards on packaging. Over half a million children are exposed to pharmaceuticals each year. A new study soon to be published in The Journal of Pediatrics attempts to understand this growing problem to aid in the progress of reducing the number of childhood injuries due to pharmaceutical poisoning.

16 Sep 2011

Practice Research Award winner describes research to support pharmacist prescribing services

"Doctors who have worked with, and patients receiving care provided by, pharmacist prescribers are highly supportive and value their prescribing roles but research indicates that the service is not being optimised due to a lack of strategic direction and policies to support its place in patient care" said Professor Derek Stewart in his keynote lecture as the winner of the Pharmacy Practice Research Trust (PPRT) 2011 Practice Research Award at the Royal Pharmaceutical Society's Conference in London.

16 Sep 2011

Diclofenac in nano-formulated doses provides effective pain relief

A novel formulation of diclofenac provides pain relief at lower-than-standard doses during a Phase II clinical study as reported today at the 2011 World Congress on Osteoarthritis.

16 Sep 2011

Synthon announces European approvals for Eplerenone

Synthon has successfully concluded multiple registration procedures for the cardiovascular drug Eplerenone. Synthon has obtained regulatory clearance for the product in nine European countries, for both 25 and 50 mg film coated tablets.

15 Sep 2011

CRF announces late breaking trials & first report investigations to be presented at TCT 2011

The Cardiovascular Research Foundation has announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2011 scientific symposium. Presented in partnership with the American College of Cardiology (ACC), TCT 2011 is the world’s leading educational meeting specializing in interventional cardiovascular medicine and will take place November 7-11, 2011 in San Francisco.

15 Sep 2011

Gates Foundation names Novartis AG executive to head global health program

The Bill & Melinda Gates Foundation on Tuesday announced that Trevor Mundel, a senior executive at the pharmaceutical company Novartis AG, will join the foundation on December 1 "as president of the philanthropy's global health group, a position that can influence the health of millions of people worldwide," the Wall Street Journal reports (Guth, 9/14).

15 Sep 2011

Hengrui, Shanghai ChemPartner enter strategic development partnership for monoclonal antibodies

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, and Jiangsu Hengrui Medicine Co., Ltd., a leading Chinese pharmaceutical company, today announced that Shanghai ChemPartner, a wholly owned subsidiary of ShangPharma, and Hengrui have entered into a strategic partnership for the development of novel therapeutic monoclonal antibodies.

15 Sep 2011

Radiant to launch new division with dermal safety study

As part of their ongoing growth strategy, Radiant has been expanding its capabilities into the Consumer Products Testing arena. In order to supplement the existing Radiant staff that has years of consumer products testing experience, Radiant has hired key technical experts to serve as Study Managers, and to assist in training and certification of personnel.

15 Sep 2011

Pharmaceuticals News and Research

President's signing of America Invents Act a huge win for innovators

New diabetes drugs linked to increased risk of pancreatitis and pancreatic cancer

Nanion’s automated patch clamp platforms show unparalleled results using stem cell derived cardiomyocytes

General Electric establishes two new joint ventures in Russia

New collaboration reinforces Sanofi's translational discovery platform for retinal diseases

Study shows increase in pediatric medication poisoning

Unlikely coalition launches effort to aid enrollment of people without insurance

Teva to invest in CDI for development of novel antiviral drugs

Viewpoints: NY Times on uninsured; Wilensky's 'sobering reflection'; caring for aging parents

TCT to showcase major scientific research breakthroughs in cardiovascular medicine

Potential new treatment for fragile X syndrome

Shorter treatment with telaprevir-based combination regimen may benefit hepatitis C patients

New study aims to reduce number of pediatric pharmaceutical poisoning

Practice Research Award winner describes research to support pharmacist prescribing services

Diclofenac in nano-formulated doses provides effective pain relief

Synthon announces European approvals for Eplerenone

CRF announces late breaking trials & first report investigations to be presented at TCT 2011

Gates Foundation names Novartis AG executive to head global health program

Hengrui, Shanghai ChemPartner enter strategic development partnership for monoclonal antibodies

Radiant to launch new division with dermal safety study

Event guide: World ADC Asia eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence